Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g Regulatory News (MIX)

  • There is currently no data for MIX

Interim Management Statement

10 Nov 2023 13:30

RNS Number : 1304T
Mobeus Income & Growth VCT PLC
10 November 2023
 

MOBEUS INCOME & GROWTH VCT PLC

("the Company")

LEI: 213800HKOSEVWS7YPH79

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2023

 

Mobeus Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 September 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 30 September 2023

(unaudited)

At 30 June 2023

(unaudited)

Net assets attributable to shareholders

£102.94 million

£100.15 million

Shares in issue

165,644,278

156,718,602

Net asset value (NAV) per share

62.15 pence

60.12 pence

Cumulative dividends paid

161.80 pence

161.80 pence

Cumulative Total return (net asset value basis) per share since inception

223.95 pence

221.92 pence

 

The NAV per share has increased by 2.03 pence in the quarter (an increase of 3.4% from the NAV per share at 30 June 2023).

 

INVESTMENT ACTIVITY DURING THE PERIOD

New Investment during the period

On 26 July 2023, the Company completed a new investment of £0.49 million into Mable Therapy Limited, a digital health platform for speech therapy and counselling for children and young adults.

 

On 3 August 2023, the Company completed a new investment of £0.48 million into Branchspace Limited, a digital retailing consultancy and software provider to the aviation and travel industry.

 

Further Investments during the period

On 4 July 2023, a follow on equity investment of £0.41 million was made into Legatics Holdings Limited, a SaaS LegalTech software provider.

 

On 11 August 2023, a follow on loan investment of £0.15 million was made into Orri Limited, an intensive day care provider for adults with eating disorders.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

There has been no activity post-quarter.

 

SHARE BUYBACK DURING THE PERIOD

On 26 September 2023, the Company purchased 946,163 of its own ordinary shares at a price of 57.11 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

DIVIDEND DECLARED DURING THE PERIOD

On 21 September 2023, a second interim dividend of 4.50 pence per share in respect of the year ending 31 December 2023 was declared and was paid on 8 November 2023 to all Shareholders whose names were on the register on 29 September 2023. Payment of this interim dividend will reduce NAV per share (shown above) to 57.65 pence and increase cumulative dividends paid to 166.30 pence per share.

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary: 020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFMFDSEDSEFF
Date   Source Headline
17th Feb 20153:09 pmRNSIssue of Equity
6th Feb 201510:41 amRNSOffer Update
15th Jan 20153:45 pmRNSOffer Update
15th Jan 20151:34 pmRNSDirector/PDMR Shareholding
15th Jan 20151:13 pmRNSIssue of Equity
23rd Dec 201412:31 pmRNSOffer Update
19th Dec 20144:32 pmRNSIssue of Supplementary Prospectus
19th Dec 20142:32 pmRNSTransaction in Own Shares
11th Dec 20147:00 amRNSStatement re Related Party Transaction
10th Dec 20145:32 pmRNSOffer for Subscription - Launch
13th Nov 20143:46 pmRNSInterim Management Statement
22nd Oct 201412:00 pmRNSIntention to launch offers for subscription
8th Oct 201412:31 pmRNSAGM Statement
1st Sep 20144:21 pmRNSTotal Voting Rights
19th Aug 201410:45 amRNSNational Storage Mechanism
13th Aug 20146:08 pmRNSHalf Yearly Report
30th Jun 20149:26 amRNSTransaction in Own Shares
10th Jun 201412:47 pmRNSDirector/PDMR Shareholding
6th Jun 201412:03 pmRNSIssue of Equity
2nd Jun 20149:39 amRNSOffer Update
2nd Jun 20149:37 amRNSOffer Update
2nd Jun 20149:33 amRNSOffer Update
2nd Jun 20149:27 amRNSOffer Update
14th May 201412:42 pmRNSTransaction in Own Shares
8th May 20144:39 pmRNSDirectorate Change
8th May 201410:22 amRNSInterim Management Statement
7th May 20145:04 pmRNSAGM Statement
7th May 20145:02 pmRNSTransaction in Own Shares
29th Apr 20143:26 pmRNSOffer Update
16th Apr 20145:21 pmRNSOffer Update
15th Apr 20142:52 pmRNSAnnual Financial Report
15th Apr 20147:00 amRNSFinal Results
7th Apr 201410:03 amRNSIssue of Equity
4th Apr 20149:14 amRNSIssue of Equity
1st Apr 20146:19 pmPRNCorrection : Director/PDMR Shareholding
1st Apr 20149:06 amPRNDirector/PDMR Shareholding
1st Apr 20149:05 amPRNIssue of Equity
26th Mar 201410:28 amPRNSupplementary Prospectus
24th Mar 20147:00 amPRNOffer Update
20th Mar 20143:42 pmPRNTransaction in Own Shares
20th Mar 201410:41 amPRNCompliance with Model Code
19th Mar 20145:55 pmPRNDividend announcement
19th Mar 20145:54 pmPRNNet Asset Value(s)
13th Feb 20141:10 pmPRNReplacement : Director/PDMR Shareholding
12th Feb 20143:39 pmPRNIssue of Equity
9th Jan 20145:39 pmPRNDirector/PDMR Shareholding
9th Jan 20145:37 pmPRNIssue of Equity
2nd Jan 201410:25 amPRNCorrection : Total Voting Rights
2nd Jan 20147:00 amPRNTotal Voting Rights
24th Dec 201312:18 pmPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.